Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated direct sales network. Founded in 1994, the company's main operations are headquartered in Little Elm, Texas.
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies' board declared quarterly dividends on its Series II and Series III Class B Convertible Preferred Stock totaling $39,050.00 and $18,561.25, respectively.
The dividends accrue at $1.00 per share per annum and cover July 1 through September 30, 2026, payable October 22, 2026 to holders of record on October 12, 2026.
This is routine preferred-dividend maintenance with no bearing on the common stock or company operations.